100 related articles for article (PubMed ID: 9428733)
1. Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay.
Beekman B; van El B; Drijfhout JW; Ronday HK; TeKoppele JM
FEBS Lett; 1997 Dec; 418(3):305-9. PubMed ID: 9428733
[TBL] [Abstract][Full Text] [Related]
2. Activation of progelatinase B in synovial fluids of patients with rheumatoid arthritis, with reference to stromelysin-1 and tissue inhibitor of matrix metalloproteinase-1.
Watanabe Y; Yamaguchi R; IwakiEgawa S; Shimamori Y; Fujimoto Y; Matsuno H
Clin Exp Rheumatol; 1999; 17(4):401-6. PubMed ID: 10464548
[TBL] [Abstract][Full Text] [Related]
3. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the appearance of gelatinases in the synovial fluid of patients with rheumatoid arthritis and polymorphonuclear elastase, stromelysin-1, and the tissue inhibitor of metalloproteinase-1.
Watanabe Y; Shimamori Y; Fujii N; Yamaguchi R; Fujimoto Y; Matsuno H
Clin Exp Rheumatol; 1997; 15(3):255-61. PubMed ID: 9177919
[TBL] [Abstract][Full Text] [Related]
5. Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Kageyama Y; Miyamoto S; Ozeki T; Hiyohsi M; Suzuki M; Nagano A
Clin Rheumatol; 2000; 19(1):14-20. PubMed ID: 10752493
[TBL] [Abstract][Full Text] [Related]
6. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.
Brama PA; TeKoppele JM; Beekman B; van El B; Barneveld A; van Weeren PR
Ann Rheum Dis; 2000 Feb; 59(2):155-7. PubMed ID: 10666176
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Nagase H; Fields CG; Fields GB
J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
[TBL] [Abstract][Full Text] [Related]
8. A high throughput fluorogenic substrate for stromelysin (MMP-3).
Bickett DM; Green MD; Wagner C; Roth JT; Berman J; McGeehan GM
Ann N Y Acad Sci; 1994 Sep; 732():351-5. PubMed ID: 7978805
[TBL] [Abstract][Full Text] [Related]
9. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
10. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media.
Beekman B; Drijfhout JW; Bloemhoff W; Ronday HK; Tak PP; te Koppele JM
FEBS Lett; 1996 Jul; 390(2):221-5. PubMed ID: 8706864
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
12. Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2.
Buisson-Legendre N; Smith S; March L; Jackson C
Arthritis Rheum; 2004 Jul; 50(7):2151-6. PubMed ID: 15248212
[TBL] [Abstract][Full Text] [Related]
13. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand.
Matsuno H; Yudoh K; Watanabe Y; Nakazawa F; Aono H; Kimura T
J Rheumatol; 2001 Jan; 28(1):22-8. PubMed ID: 11196534
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
Choi HM; Lee YA; Yang HI; Yoo MC; Kim KS
Int J Rheum Dis; 2011 Oct; 14(4):320-4. PubMed ID: 22004227
[TBL] [Abstract][Full Text] [Related]
16. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
Walakovits LA; Moore VL; Bhardwaj N; Gallick GS; Lark MW
Arthritis Rheum; 1992 Jan; 35(1):35-42. PubMed ID: 1370619
[TBL] [Abstract][Full Text] [Related]
17. No increase in synovial fluid level of matrix metalloproteinase-3 by systemic administration of glucocorticoids in rheumatoid arthritis.
Kamata Y; Minota S
Eur J Intern Med; 2015 Jun; 26(5):371-2. PubMed ID: 25820020
[No Abstract] [Full Text] [Related]
18. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
19. [Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements].
Ribbens C; Malaise M
Bull Mem Acad R Med Belg; 2001; 156(5-6):275-81; discussion 281-3. PubMed ID: 11928230
[TBL] [Abstract][Full Text] [Related]
20. A trypsin sensitive stromelysin isolated from rheumatoid synovial fluid is an activator for matrix metalloproteinases.
Kolkenbrock H; Hecker-Kia A; Orgel D; Buchlow G; Sörensen H; Hauer W; Ulbrich N
Eur J Clin Chem Clin Biochem; 1993 Oct; 31(10):625-31. PubMed ID: 8292662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
